Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

ClinicalTrials.gov ID: NCT01304524

Public ClinicalTrials.gov record NCT01304524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Placebo Controlled Study of VGX-3100, (HPV16 E6/E7, HPV18 E6/E7 DNA Vaccine) Delivered IM Followed by Electroporation With CELLECTRA-5P for the Treatment of Biopsy-proven CIN 2/3 or CIN 3 With Documented HPV 16 or 18.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is randomized, placebo controlled study to determine safety and efficacy of VGX-3100 DNA Vaccine delivered by Electroporation to adult women with biopsy-proven HPV 16 or 18 associated Cervical intraepithelial neoplasia grade 2/3 or 3.

Study identification

NCT ID
NCT01304524
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Inovio Pharmaceuticals
Industry
Enrollment
167 participants

Conditions and interventions

Interventions

Biological · Device

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2011 (Type not available)
Primary completion
May 2014 (Actual)
Completion
Apr 2015 (Actual)
Last update posted
Sep 7, 2018

2011 – 2015

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
Not listed Phoenix Arizona 85015 —
Not listed Tucson Arizona 85721 —
Not listed Colton California 92324 —
Not listed La Mesa California 91942 —
Not listed Los Angeles California 90036 —
Not listed Lakewood Colorado 80228 —
Not listed Boynton Beach Florida 33472 —
Not listed Fort Lauderdale Florida 33316 —
Not listed Sarasota Florida 34231 —
Not listed Baltimore Maryland 21205 —
Not listed Saginaw Michigan 48604 —
Not listed Missoula Montana 59808 —
Not listed Port Jefferson New York 11777 —
Not listed The Bronx New York 10467 —
Not listed Raleigh North Carolina 27607 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Columbus Ohio 43231 —
Not listed Oklahoma City Oklahoma 73117 —
Not listed Eugene Oregon 97401 —
Not listed Philadelphia Pennsylvania 19122 —
Not listed Myrtle Beach South Carolina 29572 —
Not listed Murray Utah 84107 —
Not listed Pleasant Grove Utah 84062 —
Not listed Sandy City Utah 84070 —
Not listed Richmond Virginia 23233 —
Not listed Renton Washington 98055 —
Not listed Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01304524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 7, 2018 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01304524 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →